| Overview |
| bs-15273R-PE |
| C7orf53 Polyclonal Antibody, PE Conjugated |
| WB |
| Human, Mouse, Rat, Dog |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human C7orf53 |
| 31-100/131 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 286006 |
| Cell membrane |
| C7orf53; CG053_HUMAN; Chromosome 7 open reading frame 53; Coiled-coil domain-containing transmembrane protein C7orf53. |
| Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia. The C7orf53 gene product has been provisionally designated C7orf53 pending further characterization. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz